Anti-p57 kip2 Monoclonal Antibody (Clone:IHC057)-Ready to Use

Anti-p57 kip2 Monoclonal Antibody (Clone:IHC057)-Ready to Use
Item number Size Datasheet Manual SDS Delivery time Quantity Price
ABE-44-1108-7 7 ml -

3 - 11 business days*

853.00€
 
p57kip2, also known as p57, is a tumor suppressor protein that causes cell cycle arrest at G1 by... more
Product information "Anti-p57 kip2 Monoclonal Antibody (Clone:IHC057)-Ready to Use"
p57kip2, also known as p57, is a tumor suppressor protein that causes cell cycle arrest at G1 by binding G1 cyclin-CDK complexes. The p57kip2 gene is a potential tumor suppressor target as the gene is located in a chromosomal region implicated in sporadic cancers, Wilms' tumor, and Beckwith Wiedemann syndrome. Anti-p57kip2 labels many cytotrophoblast nuclei and stromal cells in normal placenta, and is useful in differentiating between complete hydatidiform mole and partial hydatidiform mole or hydropic abortion. Protein function: Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2. Negative regulator of cell proliferation. May play a role in maintenance of the non-proliferative state throughout life. [The UniProt Consortium]
Keywords: Anti-KIP2, Anti-CDKN1C, Anti-p57Kip2, Anti-Cyclin-dependent kinase inhibitor 1C, Anti-Cyclin-dependent kinase inhibitor p57, Anti-p57 kip2 Monoclonal Antibody (Clone:IHC057)-Ready to Use
Supplier: Abeomics
Supplier-Nr: 44-1108

Properties

Application: IHC
Antibody Type: Monoclonal
Clone: IHC057
Conjugate: No
Host: Mouse
Species reactivity: human

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Anti-p57 kip2 Monoclonal Antibody (Clone:IHC057)-Ready to Use"
Write a review
or to review a product.
Viewed